CStone and Pfizer announce NMPA approval of sugemalimab in pat...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SUZHOU, China, June 6, 2022 /PRNewswire-AsiaNet/ -- * The National Medical Products Administration approved sugemalimab for the treatment of patients with unresectable stage III non-small cell lung cancer whose disease has not progressed following concurrent or sequential platinum-based chemoradiot...
Authors: LATEST ASIANET NEWS RELEASES